PT Kalbe Farma Tbk. (PTKFF)
OTCMKTS · Delayed Price · Currency is USD
0.0718
-0.0107 (-12.97%)
At close: Dec 16, 2025
PT Kalbe Farma Tbk. Market Cap
PT Kalbe Farma Tbk. has a market cap or net worth of $3.26 billion as of December 31, 2025. Its market cap has decreased by -23.61% in one year.
Market Cap
3.26B
Enterprise Value
3.15B
Revenue
2.06B
Ranking
n/a
PE Ratio
15.55
Stock Price
$0.07
Market Cap Chart
Since February 26, 1992, PT Kalbe Farma Tbk.'s market cap has increased from 96.30M to 3.26B, an increase of 3,280.62%. That is a compound annual growth rate of 10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 3.26B | -16.31% |
| Dec 30, 2024 | 3.89B | -19.49% |
| Dec 29, 2023 | 4.83B | -22.39% |
| Dec 30, 2022 | 6.23B | 17.30% |
| Dec 30, 2021 | 5.31B | 7.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.19M |
| Elite Pharmaceuticals | 503.55M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 355.02M |
| CytoDyn | 325.20M |
| Silence Therapeutics | 290.49M |